EPISODE · Feb 26, 2024 · 46 MIN
Episode 29 - Joe Murad, President & CEO at Vida Health
from Digital Health Heavyweights · host Norm Volsky
On Episode 29 of the Digital Health Heavyweights Podcast, Norm interviews Joe Murad, CEO of Vida Health. Joe discusses his journey in digital health, focusing on business flexibility and lessons from health benefits ventures. He emphasizes Vida's impact in virtual cardio metabolic care, detailing the integrated care model, personalized coaching, and data-driven clinical outcomes. Joe shares insights on leadership, GLP-1 drugs, Vida's integration with PBMs, and keys to commercial success in healthcare. Predictions for the future include increased transparency, value-based care, and integrated service delivery. Joe also shares personal wellness practices and a preview of his upcoming GLP-1 drugs panel discussion.Our Takeaways from this episode 👇🏼💡 Focus and flexibility are important in business, allowing for adaptation and seizing opportunities.💡 Building a sustainable business with differentiated capabilities is key to success in the healthcare industry.💡 Precision pharmacy and following recommended clinical pathways can greatly improve health outcomes.💡 When fundraising, it is important to have a solid plan and demonstrate how the capital will lead to cashflow break even. 💡 Integrated care delivery models that combine personalized coaching and data are crucial for achieving clinical outcomes.💡 Companies in the healthcare space should prioritize team building and foster a culture of excellence.💡 A balanced approach that combines behavioral change and medication is necessary for effective obesity management.💡 Integration with PBMs can streamline the prior authorization process and improve the member experience.💡 The future of healthcare will involve increased transparency, value-based care models, and integrated service delivery.Timestamps:00:00 Introduction and Background01:28 Transition into Healthcare04:43 Balancing Focus and Flexibility in Business07:36 Transitioning to a Larger Entity08:07 Impact of Extend Health on Health Benefits09:15 Improving the Quality of Life for Retirees10:08 Joining PocketDoc as President and CEO11:01 PocketDoc's Approach and Value in the Market12:07 Focusing on Pragmatic Components of Service Delivery14:03 Lessons Learned from Acquisitions15:31 Disrupting the Pharmacy Benefit Management Space18:04 WithMe's Approach and Impact in the Market19:44 The Importance of Precision Pharmacy21:24 Fundraising Tips for Founders22:47 Joining Vida as CEO23:39 Vida's Mission and Impact24:03 Integrated Care Delivery Model25:08 Opportunity and Momentum at Vida27:05 Leadership Philosophy28:25 Fostering a Culture of Excellence29:39 GLP-1 Drugs and Obesity Management31:19 Unintended Consequences of Overprescribing GLP-1 Drugs32:14 Integration with PBMs for Prior Authorization33:15 Member Experience at VIDA34:14 Sales and Leading a Company35:22 Commercial Success in the Healthcare Space36:21 Predictions for the Future of Healthcare41:24 Personal Wellness and Stress Management43:31 Healthy Recipes and Balanced Eating45:01 Panel Discussion on GLP-1 DrugsFollow, connect and subscribe:LinkedIn: https://www.linkedin.com/company/digital-health-heavyweights-podcastYoutube: https://youtube.com/@DigitalHealthHeavyweightsInstagram: https://www.instagram.com/digitalhealthheavyweights/TikTok: https://www.tiktok.com/@heavyweightspodcast
What this episode covers
On Episode 29 of the Digital Health Heavyweights Podcast, Norm interviews Joe Murad, CEO of Vida Health. Joe discusses his journey in digital health, focusing on business flexibility and lessons from health benefits ventures. He emphasizes Vida's impact in virtual cardio metabolic care, detailing the integrated care model, personalized coaching, and data-driven clinical outcomes. Joe shares insights on leadership, GLP-1 drugs, Vida's integration with PBMs, and keys to commercial success in he...
NOW PLAYING
Episode 29 - Joe Murad, President & CEO at Vida Health
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m